NewAmsterdam Pharma Co. NV (NAMS)
27.32
+0.46
(+1.73%)
USD |
NASDAQ |
Aug 25, 16:00
27.34
+0.02
(+0.09%)
After-Hours: 19:17
NewAmsterdam Pharma Price to Book Value : 5.090 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 5.003 |
| August 21, 2026 | 5.193 |
| August 20, 2026 | 5.176 |
| August 19, 2026 | 5.316 |
| August 18, 2026 | 5.077 |
| August 17, 2026 | 5.012 |
| August 14, 2026 | 5.027 |
| August 13, 2026 | 4.969 |
| August 12, 2026 | 5.186 |
| August 11, 2026 | 5.146 |
| August 10, 2026 | 5.214 |
| August 07, 2026 | 5.210 |
| August 06, 2026 | 5.156 |
| August 05, 2026 | 5.109 |
| August 04, 2026 | 5.133 |
| August 03, 2026 | 5.122 |
| July 31, 2026 | 5.178 |
| July 30, 2026 | 5.303 |
| July 29, 2026 | 5.200 |
| July 28, 2026 | 5.214 |
| July 27, 2026 | 5.631 |
| July 24, 2026 | 5.523 |
| July 23, 2026 | 5.692 |
| July 22, 2026 | 5.907 |
| July 21, 2026 | 6.026 |
| Date | Value |
|---|---|
| July 20, 2026 | 5.528 |
| July 17, 2026 | 5.903 |
| July 16, 2026 | 5.786 |
| July 15, 2026 | 5.959 |
| July 14, 2026 | 6.203 |
| July 13, 2026 | 6.201 |
| July 10, 2026 | 6.570 |
| July 09, 2026 | 6.693 |
| July 08, 2026 | 6.676 |
| July 07, 2026 | 6.892 |
| July 06, 2026 | 6.503 |
| July 02, 2026 | 6.490 |
| July 01, 2026 | 6.553 |
| June 30, 2026 | 6.315 |
| June 29, 2026 | 5.939 |
| June 26, 2026 | 5.828 |
| June 25, 2026 | 5.564 |
| June 24, 2026 | 5.721 |
| June 23, 2026 | 5.506 |
| June 22, 2026 | 5.404 |
| June 18, 2026 | 5.230 |
| June 17, 2026 | 5.287 |
| June 16, 2026 | 5.294 |
| June 15, 2026 | 5.366 |
| June 12, 2026 | 5.330 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ProQR Therapeutics NV | 3.673 |
| Pharming Group NV | 3.293 |
| argenx SE | -- |
| Arcutis Biotherapeutics, Inc. | 14.15 |
| Damora Therapeutics, Inc. | 4.917 |
Price to Book Value Related Metrics
| PS Ratio | 458.85 |
| PEG Ratio | -0.3578 |
| Price | 27.32 |
| Earnings Yield | -7.97% |
| Market Cap | 3.214B |
| PEGY Ratio | -0.3578 |